Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moss

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2022
Breakthrough SARS-CoV-2 Infections in Patients With Immune-Mediated Disease Undergoing B Cell-Depleting Therapy: A Retrospective Cohort AnalysisCassandra M Calabrese, Elizabeth Kirchner, Elaine M Husni, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|January 1, 1997
Three-dimensional analysis techniques--Part 4: Three-dimensional analysis of bone and soft tissue to bone ratio of movements in 24 cleft palate patients following Le Fort I osteotomy: a preliminary reportA M McCance, J P Moss, W R Fright, et al.
RMD Open|September 19, 2022
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunityCassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 29, 2012
Cord blood T cells retain early differentiation phenotype suitable for immunotherapy after TCR gene transfer to confer EBV specificityG Frumento, Y Zheng, G Aubert, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
Metabolism of captopril carboxyl ester derivatives for percutaneous absorptionDarren R Gullick, Matthew J Ingram, W John Pugh, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
The Journal of Pharmacy and Pharmacology|February 3, 2006
Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorptionGary P Moss, Darren R Gullick, Paul A Cox, et al.
Archives of Internal Medicine|August 1, 1980
Strongyloidiasis in immunosuppressed hosts. Presentation as massive lower gastrointestinal bleedingR W Powell, J P Moss, D Nagar, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2011
The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranesGary P Moss, Yi Sun, Simon C Wilkinson, et al.
Journal of Neuroimmunology|July 25, 2022
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case seriesJeffrey Lambe, Marisa P McGinley, Brandon P Moss, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2022
Breakthrough SARS-CoV-2 Infections in Patients With Immune-Mediated Disease Undergoing B Cell-Depleting Therapy: A Retrospective Cohort AnalysisCassandra M Calabrese, Elizabeth Kirchner, Elaine M Husni, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|January 1, 1997
Three-dimensional analysis techniques--Part 4: Three-dimensional analysis of bone and soft tissue to bone ratio of movements in 24 cleft palate patients following Le Fort I osteotomy: a preliminary reportA M McCance, J P Moss, W R Fright, et al.
RMD Open|September 19, 2022
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunityCassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 29, 2012
Cord blood T cells retain early differentiation phenotype suitable for immunotherapy after TCR gene transfer to confer EBV specificityG Frumento, Y Zheng, G Aubert, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
Metabolism of captopril carboxyl ester derivatives for percutaneous absorptionDarren R Gullick, Matthew J Ingram, W John Pugh, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
The Journal of Pharmacy and Pharmacology|February 3, 2006
Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorptionGary P Moss, Darren R Gullick, Paul A Cox, et al.
Archives of Internal Medicine|August 1, 1980
Strongyloidiasis in immunosuppressed hosts. Presentation as massive lower gastrointestinal bleedingR W Powell, J P Moss, D Nagar, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2011
The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranesGary P Moss, Yi Sun, Simon C Wilkinson, et al.
Journal of Neuroimmunology|July 25, 2022
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case seriesJeffrey Lambe, Marisa P McGinley, Brandon P Moss, et al.
Pageof 32